Weighted Average Number of Shares Outstanding, Diluted of CANNAPHARMARX, INC. from 31 Dec 2014 to 31 Dec 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
CANNAPHARMARX, INC. annual and quarterly Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Dec 2014 to 31 Dec 2024.
  • CANNAPHARMARX, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2024 was 662,501,405, a 125% increase year-over-year.
  • CANNAPHARMARX, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 625,276,406, a 102% increase from 2023.
  • CANNAPHARMARX, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 308,937,710, a 46% increase from 2022.
  • CANNAPHARMARX, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 211,044,357, a 183% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)

CANNAPHARMARX, INC. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 625,276,406 +316,338,696 +102% 01 Jan 2024 31 Dec 2024 10-K 10 Apr 2025 2024 FY
2023 308,937,710 +97,893,353 +46% 01 Jan 2023 31 Dec 2023 10-K 10 Apr 2025 2024 FY
2022 211,044,357 +136,357,794 +183% 01 Jan 2022 31 Dec 2022 10-K 01 Sep 2023 2022 FY
2021 74,686,563 +33,986,612 +84% 01 Jan 2021 31 Dec 2021 10-K 01 Sep 2023 2022 FY
2020 40,699,951 +9,525,015 +31% 01 Jan 2020 31 Dec 2020 10-K 14 Apr 2021 2020 FY
2019 31,174,936 +13,211,505 +74% 01 Jan 2019 31 Dec 2019 10-K 14 Apr 2021 2020 FY
2018 17,963,431 +2,690 +0.02% 01 Jan 2018 31 Dec 2018 10-K 27 May 2020 2019 FY
2017 17,960,741 0 0% 01 Jan 2017 31 Dec 2017 10-K 03 Apr 2019 2018 FY
2016 17,960,741 +2,622,389 +17% 01 Jan 2016 31 Dec 2016 10-K 14 Sep 2018 2017 FY
2015 15,338,352 +4,269,483 +39% 01 Jan 2015 31 Dec 2015 10-K 14 Sep 2018 2016 FY
2014 11,068,869 01 Jan 2014 31 Dec 2014 10-K 11 Sep 2018 2015 FY

CANNAPHARMARX, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 662,501,405 +367,405,402 +125% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q1 2024 350,519,674 +57,630,060 +20% 01 Jan 2024 31 Mar 2024 10-Q 25 Jun 2024 2024 Q1
Q4 2023 308,937,710 +97,893,353 +46% 01 Oct 2023 31 Dec 2023 10-K 10 Apr 2025 2024 FY
Q3 2023 295,096,003 +53,997,966 +22% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 299,656,064 +99,820,798 +50% 01 Apr 2023 30 Jun 2023 10-Q 13 Oct 2023 2023 Q2
Q1 2023 292,889,614 +143,674,018 +96% 01 Jan 2023 31 Mar 2023 10-Q 25 Jun 2024 2024 Q1
Q4 2022 211,044,357 +136,357,794 +183% 01 Oct 2022 31 Dec 2022 10-K 01 Sep 2023 2022 FY
Q3 2022 241,098,037 +156,682,764 +186% 01 Jul 2022 30 Sep 2022 10-Q 17 Nov 2023 2023 Q3
Q2 2022 199,835,266 +142,600,253 +249% 01 Apr 2022 30 Jun 2022 10-Q 13 Oct 2023 2023 Q2
Q1 2022 149,215,596 +101,172,531 +211% 01 Jan 2022 31 Mar 2022 10-Q 22 Sep 2023 2023 Q1
Q4 2021 74,686,563 +33,986,612 +84% 01 Oct 2021 31 Dec 2021 10-K 01 Sep 2023 2022 FY
Q3 2021 84,415,273 +44,694,573 +113% 01 Jul 2021 30 Sep 2021 10-Q 21 Nov 2022 2022 Q3
Q2 2021 57,235,013 +17,232,540 +43% 01 Apr 2021 30 Jun 2021 10-Q 22 Aug 2022 2022 Q2
Q1 2021 48,043,065 +11,556,066 +32% 01 Jan 2021 31 Mar 2021 10-Q 23 May 2022 2022 Q1
Q4 2020 40,699,951 +9,525,015 +31% 01 Oct 2020 31 Dec 2020 10-K 14 Apr 2021 2020 FY
Q3 2020 39,720,700 +5,799,509 +17% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 40,002,473 +7,698,674 +24% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2021 Q2
Q1 2020 36,486,999 +14,509,071 +66% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q4 2019 31,174,936 +13,211,505 +74% 01 Oct 2019 31 Dec 2019 10-K 14 Apr 2021 2020 FY
Q3 2019 33,921,191 +15,960,450 +89% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 32,303,799 +14,343,058 +80% 01 Apr 2019 30 Jun 2019 10-Q 19 Aug 2020 2020 Q2
Q1 2019 21,977,928 +4,017,187 +22% 01 Jan 2019 31 Mar 2019 10-Q 29 Jun 2020 2020 Q1
Q4 2018 17,963,431 +2,690 +0.02% 01 Oct 2018 31 Dec 2018 10-K 27 May 2020 2019 FY
Q3 2018 17,960,741 0 0% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 17,960,741 0 0% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 17,960,741 +270 +0% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q4 2017 17,960,741 0 0% 01 Oct 2017 31 Dec 2017 10-K 03 Apr 2019 2018 FY
Q3 2017 17,960,741 0 0% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2018 Q3
Q2 2017 17,960,741 0 0% 01 Apr 2017 30 Jun 2017 10-Q 14 Sep 2018 2018 Q2
Q1 2017 17,960,471 0 0% 01 Jan 2017 31 Mar 2017 10-Q 14 Sep 2018 2018 Q1
Q4 2016 17,960,741 +2,622,389 +17% 01 Oct 2016 31 Dec 2016 10-K 14 Sep 2018 2017 FY
Q3 2016 17,960,741 +1,120 +0.01% 01 Jul 2016 30 Sep 2016 10-Q 14 Sep 2018 2017 Q3
Q2 2016 17,960,741 -121,849 -0.67% 01 Apr 2016 30 Jun 2016 10-Q 14 Sep 2018 2017 Q2
Q1 2016 17,960,471 +485,064 +2.8% 01 Jan 2016 31 Mar 2016 10-Q 14 Sep 2018 2017 Q1
Q4 2015 15,338,352 01 Oct 2015 31 Dec 2015 10-K 14 Sep 2018 2016 FY
Q3 2015 17,959,621 01 Jul 2015 30 Sep 2015 10-Q 14 Sep 2018 2016 Q3
Q2 2015 18,082,590 01 Apr 2015 30 Jun 2015 10-Q 14 Sep 2018 2016 Q2
Q1 2015 17,475,407 01 Jan 2015 31 Mar 2015 10-Q 14 Sep 2018 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.